Form 8-K - Current report:
SEC Accession No. 0001193125-25-269526
Filing Date
2025-11-06
Accepted
2025-11-06 16:11:13
Documents
14
Period of Report
2025-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d11539d8k.htm   iXBRL 8-K 26063
2 EX-5.1 d11539dex51.htm EX-5.1 9873
6 GRAPHIC g11539g1106044241050.jpg GRAPHIC 2530
  Complete submission text file 0001193125-25-269526.txt   161743

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA calc-20251106.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20251106_lab.xml EX-101.LAB 18735
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20251106_pre.xml EX-101.PRE 11723
17 EXTRACTED XBRL INSTANCE DOCUMENT d11539d8k_htm.xml XML 3805
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 251458379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)